Notice Number: NOT-CA-18-092
Key Dates
Release Date: August 23, 2018
PAR-18-467
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to amend PAR-18-467 "The NCI Transition Career Development Award (K22 Independent Clinical Trial Not Allowed)" so that Foreign components can be part of applications from Domestic institutions that are submitted in response to it.
The following specific change is implemented:
Part 2. Section III. Eligibility Information
1. Eligible Applicants
Eligible Organizations
The language towards the end of the bulleted organizations/institutions in this section of PAR-18-467 currently reads as follows:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
That language has been revised and implemented as follows:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
All other aspects of this Funding Opportunity Announcement remain unchanged.
Inquiries
Please direct all inquiries to:
Sonia B. Jakowlew, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5630
Email: [email protected]
and Human Services (HHS)
